+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Mexico Pharmacy Retail Market Size, Share, Trends and Forecast by Market Structure, Product Type, Therapeutic Area, Drug Type, Pharmacy Location, and Region, 2026-2034

  • PDF Icon

    Report

  • 119 Pages
  • June 2026
  • Region: Mexico
  • IMARC Group
  • ID: 6245727
The Mexico pharmacy retail market size reached USD 30.7 Billion in 2025. The analyst expects the market to reach USD 50.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.56 % during 2026-2034. The aging population, rising chronic‐ disease burden driving consistent medication demand, the aggressive expansion of national chain networks complemented by omnichannel innovations, e ‐ pharmacy adoption and home ‐ delivery via marketplaces, and supportive government healthcare spending are some of the key factors catalyzing the market growth.

MEXICO PHARMACY RETAIL MARKET TRENDS:

Expansion of Omnichannel and E-Pharmacy Platforms

Mexico’s pharmacy retail sector is rapidly evolving through digital transformation, marked by the widespread adoption of omnichannel strategies and e-pharmacy services. Traditional pharmacy chains are increasingly integrating in-store offerings with digital platforms to boost convenience, accessibility, and customer retention. Since the COVID-19 pandemic, e-commerce has reshaped consumer habits, with online medicine sales in Mexico rising as a share of total retail pharmacy revenue. Major players such as Farmacias del Ahorro, Farmacias Similares, and e-marketplaces like Mercado Libre have expanded to include services such as teleconsultations, prescription fulfillment, and home delivery. This shift is largely fueled by Mexico’s rising internet penetration, which surpassed 75% of the population in 2023, according to the Federal Telecommunications Institute (IFT). Moreover, increasing smartphone adoption among older adults, key users of prescription drugs, has made digital health services more accessible. E-pharmacy platforms also leverage data to personalize user experiences, offering features like loyalty programs, automated refills, and app-based reminders that enhance adherence and drive long-term revenue growth.

Increased Demand Due to Chronic Diseases and an Aging Population

The rising incidences of chronic non-communicable diseases (NCDs), such as diabetes, hypertension, and obesity, are also significantly boosting pharmaceutical demand across Mexico. As per Mexico’s National Health and Nutrition Survey (ENSANUT), over 10 million people are living with diabetes and nearly 20 million with hypertension; these figures expected to grow through 2025, prompting frequent and sustained pharmacy visits. Simultaneously, Mexico’s aging population is contributing to this trend, with citizens aged 60 and above projected to reach 20 million by 2030, up from approximately 15 million in 2023. This demographic increasingly depends on ongoing medication regimens, wellness supplements, and health monitoring. In response, retail pharmacies are expanding their offerings to include chronic care medications, point-of-care diagnostics like glucose and blood pressure testing, and pharmaceutical consultations. Government initiatives such as Seguro Popular and broader IMSS coverage are also improving medication access for underserved, low-income groups. These factors are positioning pharmacies as vital community health hubs, delivering not only medications but also education, disease screening, and long-term care, ultimately strengthening their role and fueling sustained market growth.

MEXICO PHARMACY RETAIL MARKET SEGMENTATION:

This report provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2026-2034. The report has categorized the market based on market structure, product type, therapeutic area, drug type, and pharmacy location.

Market Structure Insights:

  • Unorganized
  • Organized
The report has provided a detailed breakup and analysis of the market based on the market structure. This includes unorganized and organized.

Product Type Insights:

  • Over-the-Counter Products
  • Prescribed Drugs
  • Non-Pharmaceutical Products
  • Medical Equipment
A detailed breakup and analysis of the market based on the product type have also been provided in the report. This includes over-the-counter products, prescribed drugs, non-pharmaceutical products, and medical equipment.

Therapeutic Area Insights:

  • Cardiovascular
  • Pain Relief/Analgesics
  • Vitamins/Minerals/Nutrients
  • Anti-Infective
  • Anti-Diabetic
  • Others
The report has provided a detailed breakup and analysis of the market based on the therapeutic area. This includes cardiovascular, pain relief/analgesics, vitamins/minerals/nutrients, anti-infective, anti-diabetic, and others.

Drug Type Insights:

  • Generic
  • Patented
A detailed breakup and analysis of the market based on the drug type have also been provided in the report. This includes generic and patented.

Pharmacy Location Insights:

  • Street/Mall Based
  • Hospital Based
The report has provided a detailed breakup and analysis of the market based on the pharmacy location. This includes street/mall based and hospital based.

Regional Insights:

  • Northern Mexico
  • Central Mexico
  • Southern Mexico
  • Others
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Mexico, Central Mexico, Southern Mexico, and others.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the Mexico pharmacy retail market performed so far and how will it perform in the coming years?
  • What is the breakup of the Mexico pharmacy retail market on the basis of market structure?
  • What is the breakup of the Mexico pharmacy retail market on the basis of product type?
  • What is the breakup of the Mexico pharmacy retail market on the basis of therapeutic area?
  • What is the breakup of the Mexico pharmacy retail market on the basis of drug type?
  • What is the breakup of the Mexico pharmacy retail market on the basis of pharmacy location?
  • What is the breakup of the Mexico pharmacy retail market on the basis of region?
  • What are the various stages in the value chain of the Mexico pharmacy retail market?
  • What are the key driving factors and challenges in the Mexico pharmacy retail market?
  • What is the structure of the Mexico pharmacy retail market and who are the key players?
  • What is the degree of competition in the Mexico pharmacy retail market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Mexico Pharmacy Retail Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Mexico Pharmacy Retail Market Landscape
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 Mexico Pharmacy Retail Market - Breakup by Market Structure
6.1 Unorganized
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Organized
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
7 Mexico Pharmacy Retail Market - Breakup by Product Type
7.1 Over-the-Counter Products
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Prescribed Drugs
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Non-Pharmaceutical Products
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
7.4 Medical Equipment
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (2026-2034)
8 Mexico Pharmacy Retail Market - Breakup by Therapeutic Area
8.1 Cardiovascular
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Pain Relief/Analgesics
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Vitamins/Minerals/Nutrients
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Anti-Infective
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Anti-Diabetic
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Others
8.6.1 Historical and Current Market Trends (2020-2025)
8.6.2 Market Forecast (2026-2034)
9 Mexico Pharmacy Retail Market - Breakup by Drug Type
9.1 Generic
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Patented
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
10 Mexico Pharmacy Retail Market - Breakup by Pharmacy Location
10.1 Street/Mall Based
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Forecast (2026-2034)
10.2 Hospital Based
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Forecast (2026-2034)
11 Mexico Pharmacy Retail Market - Breakup by Region
11.1 Northern Mexico
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2020-2025)
11.1.3 Market Breakup by Market Structure
11.1.4 Market Breakup by Product Type
11.1.5 Market Breakup by Therapeutic Area
11.1.6 Market Breakup by Drug Type
11.1.7 Market Breakup by Pharmacy Location
11.1.8 Key Players
11.1.9 Market Forecast (2026-2034)
11.2 Central Mexico
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2020-2025)
11.2.3 Market Breakup by Market Structure
11.2.4 Market Breakup by Product Type
11.2.5 Market Breakup by Therapeutic Area
11.2.6 Market Breakup by Drug Type
11.2.7 Market Breakup by Pharmacy Location
11.2.8 Key Players
11.2.9 Market Forecast (2026-2034)
11.3 Southern Mexico
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2020-2025)
11.3.3 Market Breakup by Market Structure
11.3.4 Market Breakup by Product Type
11.3.5 Market Breakup by Therapeutic Area
11.3.6 Market Breakup by Drug Type
11.3.7 Market Breakup by Pharmacy Location
11.3.8 Key Players
11.3.9 Market Forecast (2026-2034)
11.4 Others
11.4.1 Historical and Current Market Trends (2020-2025)
11.4.2 Market Forecast (2026-2034)
12 Mexico Pharmacy Retail Market - Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant
13 Profiles of Key Players
13.1 Company A
13.1.1 Business Overview
13.1.2 Services Offered
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Company B
13.2.1 Business Overview
13.2.2 Services Offered
13.2.3 Business Strategies
13.2.4 SWOT Analysis
13.2.5 Major News and Events
13.3 Company C
13.3.1 Business Overview
13.3.2 Services Offered
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Company D
13.4.1 Business Overview
13.4.2 Services Offered
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 Company E
13.5.1 Business Overview
13.5.2 Services Offered
13.5.3 Business Strategies
13.5.4 SWOT Analysis
13.5.5 Major News and Events
14 Mexico Pharmacy Retail Market - Industry Analysis
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 Appendix